Publication | Open Access

Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration

NanoparticlesNanomedicineNeurodegenerative DiseasesDisease Gene ExpressionIntranasal AdministrationEngineeringNanobiotechnologyMolecular BiologyPharmaceutical NanotechnologyNano-drug DeliveryGene DeliveryMedicineCell BiologyChitosan Nanoparticles